#USA #Morrisville #Metabolomics #Metabolon #Research Kit

Metabolon Verus™ Metabolomics Profiling Kit Now Available for Labs

Metabolon, Inc., recognized worldwide as a leader in metabolomics solutions, has recently announced that its innovative Metabolon Verus™ Metabolomics Profiling Kit is now available for order. This exciting development marks the transition of the kit from its early access phase to full commercial availability, significantly enhancing the scope of life science research in laboratories.

Overview of the Metabolon Verus™ Kit

The Metabolon Verus™ Metabolomics Profiling Kit combines sample preparation, quality control, and automated compound annotation into a single, seamless workflow. This not only streamlines laboratory operations but also facilitates access to Metabolon’s Integrated Bioinformatics Platform (IBP), ensuring that users can easily analyze and interpret their data.

Initially introduced at the 74th ASMS Conference on Mass Spectrometry in May 2026, the Metabolon Verus™ Kit is designed to extend the organization’s robust capabilities beyond centralized services, empowering laboratories around the globe.

During the Early Access Program, a total of ten laboratories across five countries evaluated the kit with diverse applications. Research studies involving microbiome analysis, allogeneic stem cell transplantation, delirium, pulmonary fibrosis, and traumatic brain injury benefited from the hands-on use of the kit, leading to valuable insights and refinements in training and customer support.

Achievements during the Trial Phase

Noteworthy outcomes from a recent ring trial included contributions from eight independent laboratories, utilizing a fed-fasted model in both plasma and urine samples. The results demonstrated a remarkable level of consistency—labs reported an average detection of 735 metabolites per plasma sample with an impressive overlap of 89% among sites. Moreover, metabolite abundance showed a strong correlation with accurate truth datasets, with a median coefficient of 0.91, emphasizing the dependable nature of the kit.

Dr. Annie Evans, the Head of Core R&D at Metabolon, noted, “Reproducibility remains one of the biggest barriers to scaling metabolomics. Our results clearly showcase how well the ring trial readout matched in terms of metabolite count and significant metabolite identification.” This emphasizes not only the innovation of the Metabolon Verus workflow but also its quality.

Bridging Multiomics Gaps

One of the core strengths of the Metabolon Verus™ Kit is its ability to uniquely integrate various omics layers—transcriptomics, proteomics, and metagenomics—into a cohesive framework. This integration enables researchers to gain a holistic view of complex biological processes, increasing efficiency for multiomics projects. With a rapid turnaround of just five days for results, it aligns perfectly with sequencing metrics and offers laboratories unprecedented control over their workflows.

As multiomics analysis becomes more prevalent across various sectors like academic research, biotechnology companies, and pharmaceutical firms, the Verus Kit addresses longstanding challenges—eliminating the need for disparate datasets and the issues that arise from time lags between omics layers.

Commitment to High-Quality Standards

Management at Metabolon views the launch of the Verus Kit as a critical milestone in achieving their mission: to deliver accessible, high-quality metabolomics without compromising scientific rigor. Ro Hastie, CEO, elaborated on the initiative, stating, “Metabolon Verus represents decades of specialized experience and reflects our dedication to delivering reproducible and insightful metabolic data.”

The kit’s key features include standardized workflows that ensure data consistency, embedded quality controls that enhance confidence in the data from the outset, and a library encompassing over 1,500 metabolites spanning 100 biochemical sub-pathways. Importantly, the kit is designed to facilitate rapid in-house metabolomics, supported by extensive training and resources that can help laboratories establish and scale their metabolomics capabilities without exhaustive developmental hurdles.

Future Implications

Having served researchers for over 25 years, Metabolon has moved to empower labs to conduct metabolomics workflows independently while tapping into the intellectual and data-processing resources that Metabolon provides. The Metabolon Verus™ Metabolomics Profiling Kit is initially set for availability in North America, with plans for international distribution launching early in 2027.

As a vital tool in the life sciences research arsenal, the Metabolon Verus™ Kit is poised to transform how researchers approach metabolomics, unlocking potential insights that could lead to breakthroughs in various medical and health-related fields.